NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

全球e臨床解決方案市場:至2023年的預測

Global eClinical Solutions Market Research Report Forecast to 2023

出版商 Market Research Future 商品編碼 911161
出版日期 內容資訊 英文 142 Pages
商品交期: 最快1-2個工作天內
價格
全球e臨床解決方案市場:至2023年的預測 Global eClinical Solutions Market Research Report Forecast to 2023
出版日期: 2019年08月31日內容資訊: 英文 142 Pages
簡介

全球e臨床解決方案市場至2023年預計將以12.24%的年複合成長率成長,2023年達到94億3,457萬美元的規模。該市場的成長要素,為生物醫藥品及製藥公司的R&D活動增加,擴大臨床試驗的支出增加,慢性疾病增加,醫療保健管理的智慧裝置的採用擴大等。

本報告提供全球e臨床解決方案市場的相關調查,市場機會,成長及阻礙因素,各類型、部署模式、臨床試驗的階段、終端用戶、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 摘要整理

  • 市場魅力分析

第2章 市場介紹

  • 定義
  • 調查範圍
  • 假設
  • 市場結構

第3章 調查方法

  • 調查方法
  • 一次調查
  • 二次調查
  • 市場規模的估計
  • 預測模式

第4章 市場動態

  • 簡介
  • 成長要素
  • 阻礙因素
  • 市場機會
  • 大趨勢

第5章 市場要素分析

  • 價值鏈分析
  • 波特的五力分析
  • 法律規範

第6章 全球市場:各類型

  • 簡介
  • 臨床資料管理系統(CDMS)
  • 非人為化及實驗供給管理(RTSM)
  • 電子臨床結果評估(eCOA)
  • 臨床試驗管理系統(CTMS)
  • 電子追踪主文件(eTMF)
  • 實驗的安全性及法規

第7章 全球市場:各部署模式

  • 簡介
  • Web為基礎、雲端基礎
  • 企業為基礎

第8章 全球市場:臨床試驗的各階段

  • 簡介
  • 階段I
  • 階段II
  • 階段III
  • 階段IV

第9章 全球市場:各終端用戶

  • 簡介
  • 受託研究機構(CRO)
  • 製藥/生物科技企業

第10章 全球市場:各地區

  • 簡介
  • 南北美洲
    • 北美
    • 南美
  • 歐洲
    • 西歐
    • 東歐
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 其他
  • 中東、非洲地區
    • 中東
    • 非洲

第11章 競爭情形

  • 企業的市場佔有率分析
    • 簡介

第12章 企業簡介

  • ERT Clinical
  • Parexel International Corporation
  • BioClinica, Inc.
  • CRF Health
  • Oracle Corporation
  • Datatrak Int.
  • Merge Healthcare Inc.
  • Medidata Solutions, Inc.
  • Omnicomm Systems, Inc.
  • MaxisIT

第13章 附錄

目錄

Global eClinical Solutions Market: Information by Type (Clinical Data Management System (CDMS), Randomization and Trial Supply Management (RTSM), Electronic Clinical Outcome Assessment (eCOA), Clinical Trial Management System (CTMS), Electronic Trial Master Files (eTMF), Trial Safety & Regulatory), Delivery Mode (Web-Based and Cloud-Based, Enterprise-Based), Clinical Trial Phase (Phase I, Phase II and Others), End User (End user Contract Research Organizations (CROs), Pharma/Biotech Companies) and Region (North America, Europe, Asia-Pacific and RoW) - Forecast till 2023

Market Analysis

To reach USD 9434.57 million by 2023, the Global eClinical Solutions Market is predictable to register a CAGR of 12.24% The eClinical solutions market is a combination of clinical technology and has the expertise which is used to recover the clinical development procedure through data management and data scrutiny. Main features describing the market progress are rising R&D events by biopharmaceutical and pharmaceutical corporations, mounting outflow on the expansion of clinical trials, increasing weight of chronic diseases, and amplified adoption of smart devices for healthcare management. The largest market share is of Americas 47.99% in 2017, and the regional market is expected to list a CAGR of 12.41 % during the forecast period. The US is one of the top markets in the region, accounting for the largest market share during the review period. However, the Canadian market is predictable to show the highest growth rate of 9.98% during the forecast period from 2018 to 2023. Cumulative outsourcing of clinical trials and availability of diverse patient population are the main drivers for market growth. The Asia-Pacific market is likely to show substantial growth during the forecast period. India is the fastest growing region owing to its large geriatric population, which is strivers the growth of the eClinical solutions market in the region. The main contributor to the growth of the regional market is Japan, followed by China. The Clinical Data Management System (CDMS) segment is expected to lead the market and register a substantial CAGR to reach USD 2579 million by the end of 2023. CDMS is considered to be the most important part of eClinical solutions. CDMS is a tool used in clinical research to manage and store the data of clinical trials. However, the electronic clinical outcome assessment (eCOA) segment is projected to exhibit the highest CAGR of 14.98% from 2018 to 2023. The increasing demand for electronic clinical outcome assessment is driving the growth of the segment. Envisioned Spectators are Investors and trade experts, Governments, associations, and industrial bodies, e Clinical solution providers, Healthcare, IT industry, Retailers, distributors, and wholesalers,

Market segmentation

Global eClinical Solutions Market is segmented into 3 segments.It is segmented by Delivery Mode i.e., Enterprise-Based and Web-Based and Cloud-Based. It is also segmented by Type wherein different types are Clinical Trial Management System (CTMS), Clinical Data Management System (CDMS), Electronic Clinical Outcome Assessment (eCOA), Electronic Trial Master Files (eTMF), Trial Safety & Regulatory Randomization and Trial Supply Management (RTSM). And one of the most important segments is by Region. In this market segmentation is based on region. North America covering US, Canada, Mexico, Europe covering Germany, UK, France, Spain, Italy, Rest of Europe, Asia-Pacific covering China, India, Japan, Australia & New Zealand, Southeast Asia, Rest of Asia-Pacific and Rest of the World covering Middle East, Africa, Latin America

Regional Analysis

North America covering US, Canada, Mexico, Europe covering Germany, UK, France, Spain, Italy, Rest of Europe, Asia-Pacific covering China, India, Japan, Australia & New Zealand, Southeast Asia, Rest of Asia-Pacific and Rest of the World covering Middle East, Africa, Latin America

Key Players

The prominent players in the global eClinical solutions market are ERT Clinical, PAREXEL International Corporation, BioClinica, Inc., CRF Health, Oracle Corporation, DATATRAK International, Inc., Merge Healthcare Inc, Medidata Solutions, Inc., Omnicomm Systems, Inc. and MaxisIT.

The players operating in the global eClinical Solutions market are focusing on product launches, along with expanding their global footprints by entering untapped markets.

Table of Contents

1 Executive Summary

  • 1.1 Market Attractiveness Analysis

2 Market Introduction

  • 2.1 Definition
  • 2.2 Scope of the Study
  • 2.3 Assumptions
  • 2.4 Market Structure

3 Research Methodology

  • 3.1 Research Process
  • 3.2 Primary Research
  • 3.3 Secondary Research
  • 3.4 Market Size Estimation
  • 3.5 Forecast Model

4 Market Dynamics

  • 4.1 Introduction
  • 4.2 Drivers
    • 4.2.1 Increasing R&D Activities by Biopharmaceutical and Pharmaceutical Companies
    • 4.2.2 Growing Expenditure in The Development of Clinical Trials
    • 4.2.3 Rising Burden of Chronic Diseases
    • 4.2.4 Increased Use of Smart Devices for Healthcare Management
  • 4.3 Restraints
    • 4.3.1 Shortage of Healthcare Professionals and Patients for Clinical Trials
    • 4.3.2 Security and Confidentiality of Data
  • 4.4 Opportunities
    • 4.4.1 Increasing R&D for Precision Medicine Will Strengthen the Market for eClinical Solutions
  • 4.5 Mega Trends

5 Market Factor Analysis

  • 5.1 Value Chain Analysis
    • 5.1.1 Inputs
    • 5.1.2 Software Development Process
    • 5.1.3 Output
    • 5.1.4 Marketing and Distribution
    • 5.1.5 Post-Selling Services
  • 5.2 Porter's Five Forces Model
    • 5.2.1 Threat of New Entrants
    • 5.2.2 Bargaining Power of Suppliers
    • 5.2.3 Bargaining Power of Buyers
    • 5.2.4 Threat of Substitutes
    • 5.2.5 Intensity of Rivalry
  • 5.3 Regulatory Framework

6 Global eClinical Solutions Market, by Type

  • 6.1 Introduction
  • 6.2 Clinical Data Management System (CDMS)
  • 6.3 Randomization and Trial Supply Management (RTSM)
  • 6.4 Electronic Clinical Outcome Assessment (eCOA)
  • 6.5 Clinical Trial Management System (CTMS)
  • 6.6 Electronic Trail Master Files (eTMF)
  • 6.7 Trial Safety & Regulatory

7 Global eClinical Solutions Market, by Delivery Mode

  • 7.1 Introduction
  • 7.2 Web Based and Cloud Based
  • 7.3 Enterprise Based

8 Global eClinical Solutions Market, by Clinical Trial Phase

  • 8.1 Introduction
  • 8.2 Phase I
  • 8.3 Phase II
  • 8.4 Phase III
  • 8.5 Phase IV

9 Global eClinical Solutions Market, by End User

  • 9.1 Introduction
  • 9.2 Contract Research Organizations (CROs)
  • 9.3 Pharma/Biotech Companies

10 Global eClinical Solutions Market, by Region

  • 10.1 Introduction
  • 10.2 Americas
    • 10.2.1 North America
      • 10.2.1.1 US
      • 10.2.1.2 Canada
    • 10.2.2 Latin America
  • 10.3 Europe
    • 10.3.1 Western Europe
      • 10.3.1.1 Germany
      • 10.3.1.2 UK
      • 10.3.1.3 France
      • 10.3.1.4 Italy
      • 10.3.1.5 Spain
      • 10.3.1.6 Rest of Western Europe
    • 10.3.2 Eastern Europe
  • 10.4 Asia-Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 South Korea
    • 10.4.6 Rest of Asia-Pacific
  • 10.5 Middle East & Africa
    • 10.5.1 Middle East
    • 10.5.2 Africa

11 Competitive Landscape

  • 11.1 Company Market Share Analysis
    • 11.1.1 Introduction

12 Company Profiles

  • 12.1 ERT Clinical
    • 12.1.1 Company Overview
    • 12.1.2 Financial Overview
    • 12.1.3 Products/Services Offered
    • 12.1.4 Key Developments
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Strategies
  • 12.2 Parexel International Corporation
    • 12.2.1 Company Overview
    • 12.2.2 Financial Overview
    • 12.2.3 Products/Services Offered
    • 12.2.4 Key Developments
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Strategies
  • 12.3 BioClinica, Inc.
    • 12.3.1 Company Overview
    • 12.3.2 Financial Overview
    • 12.3.3 Products/Services Offered
    • 12.3.4 Key Developments
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Strategies
  • 12.4 CRF Health
    • 12.4.1 Company Overview
    • 12.4.2 Financial Overview
    • 12.4.3 Products/Services Offered
    • 12.4.4 Key Developments
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Strategies
  • 12.5 Oracle Corporation
    • 12.5.1 Company Overview
    • 12.5.2 Financial Overview
    • 12.5.3 Products/Services Offered
    • 12.5.4 Key Developments
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Strategies
  • 12.6 Datatrak Int.
    • 12.6.1 Company Overview
    • 12.6.2 Financial Overview
    • 12.6.3 Products/Services Offered
    • 12.6.4 Key Developments
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Strategies
  • 12.7 Merge Healthcare Inc.
    • 12.7.1 Company Overview
    • 12.7.2 Financial Overview
    • 12.7.3 Products/Services Offered
    • 12.7.4 Key Developments
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Strategies
  • 12.8 Medidata Solutions, Inc.
    • 12.8.1 Company Overview
    • 12.8.2 Financial Overview
    • 12.8.3 Products/Services Offered
    • 12.8.4 Key Developments
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Strategies
  • 12.9 Omnicomm Systems, Inc.
    • 12.9.1 Company Overview
    • 12.9.2 Financial Overview
    • 12.9.3 Products/Services Offered
    • 12.9.4 Key Developments
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Strategies
  • 12.1 MaxisIT
    • 12.10.1 Company Overview
    • 12.10.2 Financial Overview
    • 12.10.3 Products Offering
    • 12.10.4 Key Developments
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Strategies

13 Appendix

  • 13.1 References
  • 13.2 Related Reports

List of Tables

  • TABLE 1 GLOBAL ECLINICAL SOLUTIONS MARKET, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 2 GLOBAL ECLINICAL SOLUTIONS MARKET FOR CLINICAL DATA MANAGEMENT SYSTEM (CDMS), BY REGION, 2015-2023 (USD MILLION)
  • TABLE 3 GLOBAL ECLINICAL SOLUTIONS MARKET FOR RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM), BY REGION, 2015-2023 (USD MILLION)
  • TABLE 4 GLOBAL ECLINICAL SOLUTIONS MARKET FOR ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA), BY REGION, 2015-2023 (USD MILLION)
  • TABLE 5 GLOBAL ECLINICAL SOLUTIONS MARKET FOR CLINICAL TRIAL MANAGEMENT SYSTEM (CTMS), BY REGION, 2015-2023 (USD MILLION)
  • TABLE 6 GLOBAL ECLINICAL SOLUTIONS MARKET FOR ELECTRONIC TRAIL MASTER FILES (ETMF), BY REGION, 2015-2023 (USD MILLION)
  • TABLE 7 GLOBAL ECLINICAL SOLUTIONS MARKET FOR TRIAL SAFETY & REGULATORY, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 8 GLOBAL ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2015-2023 (USD MILLION)
  • TABLE 9 GLOBAL ECLINICAL SOLUTIONS MARKET FOR WEB BASED AND CLOUD BASED, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 10 GLOBAL ECLINICAL SOLUTIONS MARKET FOR ENTERPRISE BASED, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 11 GLOBAL ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2015-2023 (USD MILLION)
  • TABLE 12 GLOBAL ECLINICAL SOLUTIONS MARKET FOR PHASE I, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 13 GLOBAL ECLINICAL SOLUTIONS MARKET FOR PHASE II, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 14 GLOBAL ECLINICAL SOLUTIONS MARKET FOR PHASE III, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 15 GLOBAL ECLINICAL SOLUTIONS MARKET FOR PHASE IV, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 16 GLOBAL ECLINICAL SOLUTIONS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 17 GLOBAL ECLINICAL SOLUTIONS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS (CROS), BY REGION, 2015-2023 (USD MILLION)
  • TABLE 18 GLOBAL ECLINICAL SOLUTIONS MARKET FOR PHARMA/BIOTECH COMPANIES, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 19 GLOBAL ECLINICAL SOLUTIONS MARKET, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 20 AMERICAS: ECLINICAL SOLUTIONS MARKET, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 21 AMERICAS: ECLINICAL SOLUTIONS MARKET, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 22 AMERICAS: ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2015-2023 (USD MILLION)
  • TABLE 23 AMERICAS: ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2015-2023 (USD MILLION)
  • TABLE 24 AMERICAS: ECLINICAL SOLUTIONS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 25 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET, BY COUNTRY, 2015-2023 (USD MILLION)
  • TABLE 26 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 27 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2015-2023 (USD MILLION)
  • TABLE 28 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2015-2023 (USD MILLION)
  • TABLE 29 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 30 US: ECLINICAL SOLUTIONS MARKET, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 31 US: ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2015-2023 (USD MILLION)
  • TABLE 32 US: ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2015-2023 (USD MILLION)
  • TABLE 33 US: ECLINICAL SOLUTIONS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 34 CANADA: ECLINICAL SOLUTIONS MARKET, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 35 CANADA: ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2015-2023 (USD MILLION)
  • TABLE 36 CANADA: ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2015-2023 (USD MILLION)
  • TABLE 37 CANADA: ECLINICAL SOLUTIONS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 38 LATIN AMERICA: ECLINICAL SOLUTIONS MARKET, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 39 LATIN AMERICA: ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2015-2023 (USD MILLION)
  • TABLE 40 LATIN AMERICA: ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2015-2023 (USD MILLION)
  • TABLE 41 LATIN AMERICA: ECLINICAL SOLUTIONS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 42 EUROPE: ECLINICAL SOLUTIONS MARKET, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 43 EUROPE: ECLINICAL SOLUTIONS MARKET BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 44 EUROPE: ECLINICAL SOLUTIONS MARKET BY CLINICAL TRIAL PHASE, 2015-2023 (USD MILLION)
  • TABLE 45 EUROPE: ECLINICAL SOLUTIONS MARKET BY DELIVERY MODE, 2015-2023 (USD MILLION)
  • TABLE 46 EUROPE: ECLINICAL SOLUTIONS MARKET BY END USER, 2015-2023 (USD MILLION)
  • TABLE 47 WESTERN EUROPE: ECLINICAL SOLUTIONS MARKET, BY COUNTRY, 2015-2023 (USD MILLION)
  • TABLE 48 WESTERN EUROPE: ECLINICAL SOLUTIONS MARKET BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 49 WESTERN EUROPE: ECLINICAL SOLUTIONS MARKET BY CLINICAL TRIAL PHASE, 2015-2023 (USD MILLION)
  • TABLE 50 WESTERN EUROPE: ECLINICAL SOLUTIONS MARKET BY DELIVERY MODE, 2015-2023 (USD MILLION)
  • TABLE 51 WESTERN EUROPE: ECLINICAL SOLUTIONS MARKET BY END USER, 2015-2023 (USD MILLION)
  • TABLE 52 GERMANY: ECLINICAL SOLUTIONS MARKET BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 53 GERMANY: ECLINICAL SOLUTIONS MARKET BY CLINICAL TRIAL PHASE, 2015-2023 (USD MILLION)
  • TABLE 54 GERMANY: ECLINICAL SOLUTIONS MARKET BY DELIVERY MODE, 2015-2023 (USD MILLION)
  • TABLE 55 GERMANY: ECLINICAL SOLUTIONS MARKET BY END USER, 2015-2023 (USD MILLION)
  • TABLE 56 UK: ECLINICAL SOLUTIONS MARKET BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 57 UK: ECLINICAL SOLUTIONS MARKET BY CLINICAL TRIAL PHASE, 2015-2023 (USD MILLION)
  • TABLE 58 UK: ECLINICAL SOLUTIONS MARKET BY DELIVERY MODE, 2015-2023 (USD MILLION)
  • TABLE 59 UK: ECLINICAL SOLUTIONS MARKET BY END USER, 2015-2023 (USD MILLION)
  • TABLE 60 FRANCE: ECLINICAL SOLUTIONS MARKET BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 61 FRANCE: ECLINICAL SOLUTIONS MARKET BY CLINICAL TRIAL PHASE, 2015-2023 (USD MILLION)
  • TABLE 62 FRANCE: ECLINICAL SOLUTIONS MARKET BY DELIVERY MODE, 2015-2023 (USD MILLION)
  • TABLE 63 FRANCE: ECLINICAL SOLUTIONS MARKET BY END USER, 2015-2023 (USD MILLION)
  • TABLE 64 ITALY: ECLINICAL SOLUTIONS MARKET BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 65 ITALY: ECLINICAL SOLUTIONS MARKET BY CLINICAL TRIAL PHASE, 2015-2023 (USD MILLION)
  • TABLE 66 ITALY: ECLINICAL SOLUTIONS MARKET BY DELIVERY MODE, 2015-2023 (USD MILLION)
  • TABLE 67 ITALY: ECLINICAL SOLUTIONS MARKET BY END USER, 2015-2023 (USD MILLION)
  • TABLE 68 SPAIN: ECLINICAL SOLUTIONS MARKET BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 69 SPAIN: ECLINICAL SOLUTIONS MARKET BY CLINICAL TRIAL PHASE, 2015-2023 (USD MILLION)
  • TABLE 70 SPAIN: ECLINICAL SOLUTIONS MARKET BY DELIVERY MODE, 2015-2023 (USD MILLION)
  • TABLE 71 SPAIN: ECLINICAL SOLUTIONS MARKET BY END USER, 2015-2023 (USD MILLION)
  • TABLE 72 REST OF WESTERN EUROPE: ECLINICAL SOLUTIONS MARKET BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 73 REST OF WESTERN EUROPE: ECLINICAL SOLUTIONS MARKET BY CLINICAL TRIAL PHASE, 2015-2023 (USD MILLION)
  • TABLE 74 REST OF WESTERN EUROPE: ECLINICAL SOLUTIONS MARKET BY DELIVERY MODE, 2015-2023 (USD MILLION)
  • TABLE 75 REST OF WESTERN EUROPE: ECLINICAL SOLUTIONS MARKET BY END USER, 2015-2023 (USD MILLION)
  • TABLE 76 EASTERN EUROPE: ECLINICAL SOLUTIONS MARKET BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 77 EASTERN EUROPE: ECLINICAL SOLUTIONS MARKET BY CLINICAL TRIAL PHASE, 2015-2023 (USD MILLION)
  • TABLE 78 EASTERN EUROPE: ECLINICAL SOLUTIONS MARKET BY DELIVERY MODE, 2015-2023 (USD MILLION)
  • TABLE 79 EASTERN EUROPE: ECLINICAL SOLUTIONS MARKET BY END USER, 2015-2023 (USD MILLION)
  • TABLE 80 ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET, BY COUNTRY, 2015-2023 (USD MILLION)
  • TABLE 81 ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 82 ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2015-2023 (USD MILLION)
  • TABLE 83 ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2015-2023 (USD MILLION)
  • TABLE 84 ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 85 JAPAN: ECLINICAL SOLUTIONS MARKET, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 86 JAPAN: ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2015-2023 (USD MILLION)
  • TABLE 87 JAPAN: ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2015-2023 (USD MILLION)
  • TABLE 88 JAPAN: ECLINICAL SOLUTIONS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 89 CHINA: ECLINICAL SOLUTIONS MARKET, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 90 CHINA: ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2015-2023 (USD MILLION)
  • TABLE 91 CHINA: ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2015-2023 (USD MILLION)
  • TABLE 92 CHINA: ECLINICAL SOLUTIONS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 93 INDIA: ECLINICAL SOLUTIONS MARKET, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 94 INDIA: ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2015-2023 (USD MILLION)
  • TABLE 95 INDIA: ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2015-2023 (USD MILLION)
  • TABLE 96 INDIA: ECLINICAL SOLUTIONS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 97 AUSTRALIA: ECLINICAL SOLUTIONS MARKET, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 98 AUSTRALIA: ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2015-2023 (USD MILLION)
  • TABLE 99 AUSTRALIA: ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2015-2023 (USD MILLION)
  • TABLE 100 AUSTRALIA: ECLINICAL SOLUTIONS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 101 SOUTH KOREA: ECLINICAL SOLUTIONS MARKET, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 102 SOUTH KOREA: ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2015-2023 (USD MILLION)
  • TABLE 103 SOUTH KOREA: ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2015-2023 (USD MILLION)
  • TABLE 104 SOUTH KOREA: ECLINICAL SOLUTIONS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 105 REST OF ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 106 REST OF ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2015-2023 (USD MILLION)
  • TABLE 107 REST OF ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2015-2023 (USD MILLION)
  • TABLE 108 REST OF ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 109 MIDDLE EAST & AFRICA: ECLINICAL SOLUTIONS MARKET, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 110 MIDDLE EAST & AFRICA: ECLINICAL SOLUTIONS MARKET BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 111 MIDDLE EAST & AFRICA: ECLINICAL SOLUTIONS MARKET BY DELIVERY MODE, 2015-2023 (USD MILLION)
  • TABLE 112 MIDDLE EAST & AFRICA: ECLINICAL SOLUTIONS MARKET BY CLINICAL TRIAL PHASE, 2015-2023 (USD MILLION)
  • TABLE 113 MIDDLE EAST & AFRICA: ECLINICAL SOLUTIONS MARKET BY END USER, 2015-2023 (USD MILLION)
  • TABLE 114 MIDDLE EAST: ECLINICAL SOLUTIONS MARKET BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 115 MIDDLE EAST: ECLINICAL SOLUTIONS MARKET BY DELIVERY MODE, 2015-2023 (USD MILLION)
  • TABLE 116 MIDDLE EAST: ECLINICAL SOLUTIONS MARKET BY CLINICAL TRIAL PHASE, 2015-2023 (USD MILLION)
  • TABLE 117 MIDDLE EAST: ECLINICAL SOLUTIONS MARKET BY END USER, 2015-2023 (USD MILLION)
  • TABLE 118 AFRICA: ECLINICAL SOLUTIONS MARKET BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 119 AFRICA: ECLINICAL SOLUTIONS MARKET BY DELIVERY MODE, 2015-2023 (USD MILLION)
  • TABLE 120 AFRICA: ECLINICAL SOLUTIONS MARKET BY CLINICAL TRIAL PHASE, 2015-2023 (USD MILLION)
  • TABLE 121 AFRICA: ECLINICAL SOLUTIONS MARKET BY END USER, 2015-2023 (USD MILLION)

List of Figures

  • FIGURE 1 MARKET SYNOPSIS
  • FIGURE 2 MARKET ATTRACTIVENESS ANALYSIS: GLOBAL ECLINICAL SOLUTIONS MARKET
  • FIGURE 3 GLOBAL ECLINICAL SOLUTIONS MARKET SHARE, BY TYPE, 2017 (%)
  • FIGURE 4 GLOBAL ECLINICAL SOLUTIONS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • FIGURE 5 GLOBAL ECLINICAL SOLUTIONS MARKET SHARE, BY DELIVERY MODE, 2017 (%)
  • FIGURE 6 GLOBAL ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2016-2023 (USD MILLION)
  • FIGURE 7 GLOBAL ECLINICAL SOLUTIONS MARKET SHARE, BY CLINICAL TRIAL PHASE, 2017 (%)
  • FIGURE 8 GLOBAL ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2016-2023 (USD MILLION)
  • FIGURE 9 GLOBAL ECLINICAL SOLUTIONS MARKET SHARE, BY END USER, 2017 (%)
  • FIGURE 10 GLOBAL ECLINICAL SOLUTIONS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • FIGURE 11 GLOBAL ECLINICAL SOLUTIONS MARKET: MARKET STRUCTURE
  • FIGURE 12 RESEARCH PROCESS OF MRFR
  • FIGURE 13 TOP-DOWN & BOTTOM-UP APPROACH
  • FIGURE 14 MARKET DYNAMICS: ANALYSIS OF GLOBAL ECLINICAL SOLUTIONS MARKET
  • FIGURE 15 VALUE CHAIN: GLOBAL ECLINICAL SOLUTIONS MARKET
  • FIGURE 16 PORTER'S FIVE FORCES ANALYSIS OF THE GLOBAL ECLINICAL SOLUTIONS MARKET
  • FIGURE 17 GLOBAL ECLINICAL SOLUTIONS MARKET SHARE, BY TYPE, 2017(%)
  • FIGURE 18 GLOBAL ECLINICAL SOLUTIONS MARKET, BY TYPE, 2017 & 2023 (USD MILLION)
  • FIGURE 19 GLOBAL ECLINICAL SOLUTIONS MARKET SHARE, BY DELIVERY MODE, 2017 (%)
  • FIGURE 20 GLOBAL ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2017 & 2023 (USD MILLION)
  • FIGURE 21 GLOBAL ECLINICAL SOLUTIONS MARKET SHARE, BY CLINICAL TRIAL PHASE, 2017(%)
  • FIGURE 22 GLOBAL ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2017 & 2023 (USD MILLION)
  • FIGURE 23 GLOBAL ECLINICAL SOLUTIONS MARKET SHARE, BY END USER, 2017(%)
  • FIGURE 24 GLOBAL ECLINICAL SOLUTIONS MARKET, BY END USER, 2017 & 2023 (USD MILLION)
  • FIGURE 25 GLOBAL ECLINICAL SOLUTIONS MARKET SHARE, BY REGION, 2017(%)
  • FIGURE 26 GLOBAL ECLINICAL SOLUTIONS MARKET, BY REGION, 2017 & 2023 (USD MILLION)
  • FIGURE 27 AMERICAS: ECLINICAL SOLUTIONS MARKET SHARE, BY REGION, 2017 (%)
  • FIGURE 28 EUROPE: ECLINICAL SOLUTIONS MARKET SHARE, BY REGION, 2017 (%)
  • FIGURE 29 ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SHARE, BY COUNTRY, 2017 (%)
  • FIGURE 30 MIDDLE EAST & AFRICA: ECLINICAL SOLUTIONS MARKET SHARE, BY REGION, 2017 (%)
  • FIGURE 31 GLOBAL ECLINICAL SOLUTIONS MARKET, MARKET SHARE ANALYSIS, 2017 (% SHARE)